Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Galectin Therapeutics Inc (GALT)

97 + Investors. Track Smart Money conviction in GALT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
2Q ▲
Buyers last Q
55%

Smart Money Signals — GALT

Based on 97 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added GALT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
97 hedge funds hold GALT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +8% more funds vs a year ago

fund count last 6Q
+7 new funds entered over the past year (+8% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 55% buying

52 buying42 selling
Last quarter: 52 funds bought or added vs 42 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~19 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 15 → 15 → 24 → 19. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

53% of holders stayed for 2+ years

■ 53% conviction (2yr+) ■ 23% medium ■ 25% new
51 out of 97 hedge funds have held GALT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +25%, value -17%

Value
-17%
Shares
+24%
Last quarter: funds added +25% more shares while total portfolio value only changed -17%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

12 → 15 → 15 → 24 → 19 new funds/Q
New funds entering each quarter: 15 → 15 → 24 → 19. A growing number of institutions are discovering GALT each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 63% of holders stayed 2+ years

■ 63% veterans ■ 12% 1-2yr ■ 25% new
Of 102 current holders: 64 (63%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 31% AUM from major funds

31% from top-100 AUM funds
25 of 97 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.8
out of 10
Low Exit Risk
Exit risk score 3.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — GALT

In 2026 Q1, 52 hedge funds were net buyers of GALT (19 opened a new position, 33 added to an existing one), while 42 reduced or exited (24 trimmed, 18 sold completely) — a 55% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 31% of total institutional value in GALT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +1 funds (more new holders than closures). Total institutional holders: 97.

Hedge Fund Ownership: GALT

How many hedge funds hold GALT — quarterly history vs. share price
Quarterly hedge fund ownership of GALT vs. share price

Market Analysis: GALT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GALT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Galectin Therapeutics Inc (GALT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much GALT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 78d ago
GALT
-0.7%
XLV
+2.8%

GALT outperformed XLV by -3.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 33d ago
GALT
+27.6%
XLV
+3.9%

Since the filing became public, GALT outperformed XLV by +23.7% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 0 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: GALT
97 + Investors

Track Smart Money conviction in GALT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 97 96 1.04%
13F Shares 15M 12M 24.83%
Total Value $42M $51M -17.3%
New Positions 19 24 -5
Increased Positions 31 30 +1
Closed Positions 18 11 +7
Reduced Positions 24 21 +3
Total Calls 5 4 25.0%
Total Puts 2 1 100.0%
PUT/CALL Ratio 0.4 0.25 Bullish

Statistics: GALT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

97 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GALT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 GALT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Great Point Partners LLC 0.51% 800,000 $2.2M
2 Retirement Guys Formula LLC 0.24% 187,062 $522K
3 Solutions 4 Wealth, Ltd 0.11% 25,027 $70K
4 Vivaldi Capital Management LP 0.10% 258,584 $721K
5 Sovran Advisors, LLC 0.05% 257,830 $585K
6 Fortis Capital Advisors, LLC 0.04% 106,139 $296K
7 Argyle Capital Partners, LLC 0.03% 13,375 $37K
8 683 Capital Management, LLC 0.02% 162,484 $453K
9 Wealthspire Advisors, LLC 0.02% 721,788 $2.0M
10 Geneos Wealth Management Inc. 0.02% 240,927 $672K
11 Diametric Capital, LP 0.01% 17,089 $48K
12 Belpointe Asset Management LLC 0.01% 106,139 $296K
13 Catalyst Funds Management Pty Ltd 0.01% 22,500 $63K
14 Pekin Hardy Strauss, Inc. 0.01% 30,000 $84K
15 Archer Investment Corp 0.01% 13,501 $38K
16 NINE MASTS CAPITAL Ltd 0.01% 19,324 $54K
17 Inspire Advisors, LLC 0.00% 21,095 $59K
18 Osaic Holdings, INC. 0.00% 1,122,670 $3.1M
19 Cahaba Wealth Management, INC. 0.00% 21,000 $59K
20 Marshall Wace, LLP 0.00% 1,219,912 $3.4M
21 Gladstone Institutional Advisory LLC 0.00% 23,900 $67K
22 Atwood & Palmer Inc 0.00% 10,000 $28K
23 Horizon Kinetics Asset Management LLC 0.00% 49,226 $137K
24 Commonwealth Equity Services, LLC 0.00% 367,113 $1.0M
25 Hilton Head Capital Partners, LLC 0.00% 800 $2K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Galectin Therapeutics Inc (GALT)

What does the Smart Money Trend signal show for GALT?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added GALT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for GALT?

Slight buying edge — 55% buying: Last quarter: 52 funds bought or added vs 42 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for GALT holders?

Strong quality — 31% AUM from major funds: 25 of 97 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held GALT?

53% of holders stayed for 2+ years: 51 out of 97 hedge funds have held GALT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Galectin Therapeutics Inc (GALT) following the 2026 Q1 hedge fund 13F filings?

As of today, GALT has moved +27.6% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +23.7%. Since the quarter end (March 31, 2026), GALT has gained -0.7% vs +2.8% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →